NIMRAD

Trial description
A randomised placebo-controlled trial of synchronous NIMorazole versus RADiotherapy alone in patients with locally advanced head and neck squamous cell carcinoma not suitable for synchronous chemotherapy or cetuximab
Contact name
Dr Gill Barnett
Trial start date
Friday, October 24, 2014
Trial end date
Tuesday, November 6, 2018
Trial tumour type
Head & neck
Show on Radiotherapy
Yes